Recruitment to Phase 2 of the Fenland study has now been completed.
In September 2014 we launched Phase 2 of the Fenland Study. Over the next 4 years we sent invitations to participants who attended an initial Fenland Study visit between 2005 and 2015, and who agreed to be re-contacted, to return for a 2nd visit. It was entirely up to participants to decide whether or not they wish to take part in Phase 2, but the more participants who returned for Phase 2 the better will be quality of information the study provides.
The information we collect in Phase 2 will be used to study the relationship between changes in objectively measured activity and dietary behaviours and body composition, and subsequent risk of developing type 2 diabetes and other relevant health conditions. It will also help us to understand the determinants of changes in all these factors.
Participation in Phase 2 of the study involves a single morning visit of 3 1/2 hours, at one of our Research Units at either the Princess of Wales Hospital in Ely, the North Cambridgeshire Hospital in Wisbech or Addenbrooke’s Hospital in Cambridge, whichever is most convenient.
As at least 4 years need to have elapsed between the first and second visits, we did not invite all Fenland Phase 1 participants back for a 2nd visit immediately.
During this visit most of the measurements that were carried out during the Phase 1 visit are repeated, and we are also collecting some new information. In Phase 2 we also invited some participants to donate a blood sample for the generation of induced pluripotent stem cells (iPSCs) for research purposes.
For more information on the measurements that will be undertaken during your visit please see the Fenland Phase 2 Measurements page.
Study volunteers have the right to opt out of any part of the study at any time if they wish. Download the Fenland Study privacy notice.